United Urban Investment Corporation (8960.T)
JPY 135600.0
(0.07%)
JPY 135600.0
(0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 27.74 Billion | 26.57 Billion | 22.17 Billion | 26.12 Billion | 28.07 Billion | 27.56 Billion |
| Net Income | 20.29 Billion | 19.29 Billion | 17.17 Billion | 19.28 Billion | 22.95 Billion | 23.76 Billion |
| Depreciation & Amortization | 8.13 Billion | 8.17 Billion | 8.22 Billion | 8.27 Billion | 8.18 Billion | 8.21 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 110.74 Million | 723.74 Million | -1.49 Billion | 1.84 Billion | -158.08 Million | -1.22 Billion |
| Other non-cash items | 15.58 Billion | -1.61 Billion | -1.73 Billion | -3.28 Billion | -2.9 Billion | -3.18 Billion |
| Investing Cash Flow | -14.05 Billion | -10.83 Billion | -19.18 Billion | -15.4 Billion | -29.51 Billion | -4.9 Billion |
| Investments in PPE | -16.63 Billion | -18.54 Billion | -36.05 Billion | -34.42 Billion | -42.29 Billion | -29.98 Billion |
| Acquisitions | 1.42 Billion | 6.8 Billion | 13.77 Billion | 18.4 Billion | 10.84 Billion | 1.01 Million |
| Investment purchases | -814.8 Million | -1.45 Billion | -533.17 Million | -1.84 Billion | -525 Million | -1.96 Billion |
| Sales/Maturities of investments | 1.91 Billion | 2.24 Billion | 3.46 Billion | 2.09 Billion | 2.42 Billion | 3.78 Billion |
| Other Investing Activities | 1.15 Billion | 110.88 Million | 159.39 Million | 361.79 Million | 35.45 Million | 23.26 Billion |
| Financing Cash Flow | -9.32 Billion | -13.4 Billion | -11.89 Billion | 4.28 Billion | 2.26 Billion | -35.33 Billion |
| Debt repayment | -18.41 Billion | -28.9 Billion | -39.4 Billion | -35.37 Billion | -25.2 Billion | -58.02 Billion |
| Dividends payments | -19.74 Billion | -19.36 Billion | -19.64 Billion | -21.52 Billion | -21.79 Billion | -21.04 Billion |
| Common Stock Repurchased | -3 Billion | -3 Billion | - | - | -10.72 Billion | - |
| Common Stock Issuance | - | 3 Billion | - | - | 10.72 Billion | - |
| Other Financing Activities | -8 Billion | 34.86 Billion | 47.15 Billion | 61.19 Billion | 49.26 Billion | 43.72 Billion |
| Accounts receivables | 51.63 Million | -44.92 Million | 21.02 Million | 73.13 Million | -10.97 Million | -129.96 Million |
| Accounts payables | -163.85 Million | -247.05 Million | 372.74 Million | -305.43 Million | 143.74 Million | -349.4 Million |
| Inventory | - | 43.67 Million | -63.58 Million | 51.06 Million | -91.26 Million | - |
| Other working capital | 222.96 Million | 972.05 Million | -1.82 Billion | 2.02 Billion | -199.58 Million | -951.55 Million |
| Cash at beginning of period | 58.9 Billion | 119.67 Billion | 119.05 Billion | 100.08 Billion | 118.27 Billion | 111.99 Billion |
| Cash at end of period | 63.26 Billion | 122.01 Billion | 110.13 Billion | 115.09 Billion | 119.09 Billion | 99.31 Billion |
| Capital Expenditure | -16.63 Billion | -18.54 Billion | -36.05 Billion | -34.42 Billion | -42.29 Billion | -29.98 Billion |
| Effect of forex changes on cash | -1.21 Million | - | -2000.00 | 1000.00 | - | - |
| Net cash flow / Change in cash | 4.36 Billion | 2.33 Billion | -8.91 Billion | 15 Billion | 822.34 Million | -12.67 Billion |
| Free Cash Flow | 11.1 Billion | 8.03 Billion | -13.88 Billion | -8.3 Billion | -14.21 Billion | -2.42 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.58 Billion | 5.58 Billion | 10.36 Billion | 20.29 Billion | 5.18 Billion | 9.92 Billion |
| Depreciation & Amortization | 2.04 Billion | 2.03 Billion | 4.06 Billion | 8.13 Billion | 2.03 Billion | 4.06 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -385.47 Million | -507.34 Million | 308.98 Million | 110.74 Million | 598.74 Million | -198.23 Million |
| Other non-cash items | -233.31 Million | -105.46 Million | 8.36 Billion | 15.58 Billion | -561.23 Million | 7.21 Billion |
| Investing Cash Flow | -3.97 Billion | -3.97 Billion | -5.39 Billion | -14.05 Billion | -2.69 Billion | -8.65 Billion |
| Investments in PPE | -14.25 Billion | - | -7.06 Billion | -16.63 Billion | - | -9.56 Billion |
| Acquisitions | 5.84 Billion | - | 1.42 Billion | 1.42 Billion | - | - |
| Investment purchases | - | - | - | -814.8 Million | - | - |
| Sales/Maturities of investments | - | - | - | 1.91 Billion | - | - |
| Other Investing Activities | -3.97 Billion | -3.97 Billion | 239.24 Million | 1.15 Billion | -2.69 Billion | 911.86 Million |
| Financing Cash Flow | -2.72 Billion | -2.72 Billion | -6.58 Billion | -9.32 Billion | -3.29 Billion | -2.73 Billion |
| Debt repayment | -5 Billion | - | -10.41 Billion | -18.41 Billion | - | -8 Billion |
| Dividends payments | -10.44 Billion | -5.22 Billion | -10 Billion | -19.74 Billion | -5 Billion | -9.73 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.5 Billion | 2.5 Billion | -7 Billion | -8 Billion | 1.7 Billion | -1 Billion |
| Accounts receivables | -150.7 Million | -150.7 Million | -13.99 Million | 51.63 Million | -6.99 Million | 65.63 Million |
| Accounts payables | -24.45 Million | - | -450.34 Million | -163.85 Million | - | 286.49 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -234.77 Million | -356.64 Million | 773.32 Million | 222.96 Million | 605.74 Million | -550.36 Million |
| Cash at beginning of period | 63.26 Billion | - | 60.73 Billion | 58.9 Billion | - | 58.9 Billion |
| Cash at end of period | 63.89 Billion | 312.44 Million | 63.26 Billion | 63.26 Billion | 1.26 Billion | 60.73 Billion |
| Capital Expenditure | -14.25 Billion | - | -7.06 Billion | -16.63 Billion | - | -9.56 Billion |
| Effect of forex changes on cash | - | - | -1.21 Million | -1.21 Million | - | -1000.00 |
| Net cash flow / Change in cash | 624.89 Million | 312.44 Million | 2.52 Billion | 4.36 Billion | 1.26 Billion | 1.83 Billion |
| Free Cash Flow | -7.24 Billion | 7 Billion | 7.44 Billion | 11.1 Billion | 7.25 Billion | 3.65 Billion |
ORCHPHARMA
SKHCF
CDGLY
008930
ZOREN
600703